Status:
RECRUITING
Assessment of Personalized Follow-up in Prevention of Type 2 Diabetes
Lead Sponsor:
Ramsay Générale de Santé
Collaborating Sponsors:
European Clinical Trial Experts Network
Conditions:
Diabete Type 2
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
In France, the overall prevalence of diabetes was estimated at 5% of population in 2016, type 2 diabetes (T2DM) corresponding to 90% of cases. However, this figure is greatly underestimated,since it d...
Detailed Description
In France, the overall prevalence of diabetes was estimated at 5% of population in 2016, type 2 diabetes (T2DM) corresponding to 90% of cases. However, this figure is greatly underestimated. since it ...
Eligibility Criteria
Inclusion
- Patient, male or female, over the age of 18
- Patient with a FINDRISC score ≥10 points
- Beneficiary of a French health insurance system
- Patient having been informed and having given their consent free, enlightened and written
Exclusion
- Patient over 75 years old
- Patient already diagnosed with type 2 diabetes
- Patient whose physical and/or psychological health is severely impaired, which according to the investigator may affect the compliance of the study participant.
- Patient participating in another research
- Patient in period of exclusion from another research always in progress at the time of inclusion.
- Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by court order or administration.
- Pregnant, breastfeeding or parturient women.
- Patient hospitalized without consent
Key Trial Info
Start Date :
March 20 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2028
Estimated Enrollment :
230 Patients enrolled
Trial Details
Trial ID
NCT05325710
Start Date
March 20 2022
End Date
April 1 2028
Last Update
April 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique Aguiléra
Biarritz, Aquitaine, France, 64200